Real-time enrollment status for this diffuse large b cell lymphoma clinical trial
Current Status
Withdrawn
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT07030699 |
| Recruiting Status | Withdrawn |
| Condition | Diffuse Large B Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 27 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | April 7, 2026 (1 week ago) |
As of April 18, 2026: Clinical trial NCT07030699 is currently withdrawn participants. This clinical trial study for diffuse large b cell lymphoma is not currently accepting new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07030699 is currently withdrawn. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07030699 was last updated 1 week ago (April 7, 2026). HelloStudys verifies this status automatically.